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Disinfection of root canals followed by the replacement of the infected or inﬂamed pulp tissues
by inert materials is the foundation for treating irreversible damaged dental pulps. The
management of pathological conditions of the periodontium is mainly based solely upon
infection control via the reestablishment of oral hygiene, scaling and root planing to control
inﬂammation which stops progressive bone loss. As one may see, the clinical management of
endodontic and periodontal diseases has not changed drastically despite the development of
new materials, techniques and medicaments. Tissue engineering is a multi-disciplinary ﬁeld
focused on the development of materials, techniques and strategies to improve or replace
damaged or lost biological functions and tissues. As the tissue engineering ﬁeld progresses,
“scaffolds”, “suggest pathways” and “stem cells” abandoned their role as technical words
exclusively used by scientists and slowly assume a part in the language of students, educators,
clinicians and patients. However the unfamiliarity with some of the concepts can lead to
misinterpretations of the current status and overexcitement about future applications of stem
cells for dental-related tissue regeneration. This paper will present a panorama and the future
challenges on the path to use of stem cells for endodontic and periodontal tissue regeneration.
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Stem cells are clonogenic cells capable of self-renewal and
are classiﬁed according to their potency, that is, the range of
cell types they can differentiate into. This is directly relateded by Elsevier B.V.to the stages of cell division and differentiation of the human
embryo during different stages of development which begin
with a zygote, a totipotent cell that divides into identical
totipotent cells in the ﬁrst hours from the fertilization of an
egg by a sperm. Totipotent stem cells can form embryonic
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tiation potential. In fact, they can differentiate into each of
the more than 200 cell types of the adult body [1].
As development advances, the totipotent cells under-
go differentiation and segregation into more limited cell
lineages [1]. After reaching a 16-cell stage, they differentiate
into cells that will ﬁnally convert to either the trophoblasts
(ﬁrst embryonic epithelium) or embryoblast. The latter is the
blastocyst's inner cell mass that contains pluripotent
embryonic stem cells (ESC) that can differentiate into any of
the three germ layers (endoderm, mesoderm or ectoderm). As
the ESCs have such outstanding differntiation potential, their
clinical problems may be fraught with immunological
rejection and ethical concerns. In 2006, a groundbreaking
approach allowed researchers to induce pluripotency in
somatic cells by introducing four transcription factors (OCT4
and SOX2 with the combination of either KLF4 and MYC or
NANOG and LIN 28) into dermal ﬁbroblast. This discovery has
shed light on the possibility of obtaining autologous pluripo-
tent embryonic-like stem cells without the need of dealing
with nuclear transfer and embryos, the so-called induced
pluripotent stem cells (iPSC) [2].
Additionally, multipotent or adult stem cells are undiffer-
entiated cells that provide some or the entire major specia-
lized cell types to allow the repair and maintenance of the
tissue where they reside. Multipotent stem cells are able to
cross lineage boundaries and differentiate into multiple, but
limited number of cell types. For instance, a multipotent
blood stem cell is a hematopoietic cell that can differentiate
into several types of blood cell types (such as neutrophils and
lymphocytes) but cannot differentiate into brain cells, bone
cells or other non-blood cell types. In the bottom of the
differentiation hierarchy are the oligopotent and unipotent
stem cells, that can differentiate into a few cell types or only
reproduce their own phenotype, respectively [1].
The oral cavity harbors various types of multipotent stem
cells such as PDLSC (periodontal ligament stem cell) [3], SCAP
(stem cells from apical papilla) [4] and dental follicle stem
cells [5,6] (Table 1). Considering oral mucosa and gingiva,
recognized reservoirs for mesenchymal stem cells [7–9].
Although bone marrow stem cells are well-established and
are considered the gold standard for research targeting stem
cells therapies, the oral cavity can provide stem cells with
simple and less invasive procedures (especially compared toTable 1 – Stem cells from oral sources.
Year of
isolation
Population Characteristi
2000 Dental pulp stem cells (DPSC) Ability to reg
2003 Stem cells from human exfoliated
deciduous teeth (SHED)
Dental pulp a
2004 Periodontal ligament stem cells (PDLSC) Form functio
ligament inc
2005 Dental follicle stem cells Capability to
osteogenic li
2006 Stem cells from apical papilla (SCAP) Osteo/dentin
2009 Stem cells from gingiva Capacity to d
and to modubone marrow aspiration), under local anesthesia and without
esthetic damage. Additionally, dental pulp stem cells (DPSC)
and stem cells from human exfoliated deciduous teeth
(SHED) can be found in the dental pulp of permanent and
deciduous teeth, respectively [10,11]. As the latter are retrie-
vable from naturally exfoliated teeth, which are one of the
only disposable post-natal human tissues, the interest
towards SHED has increased [12]. In fact, primary teeth offer
a second chance to those parents who have not opted to save
the umbilical cord for possible future needs. Due to its ability
to cross lineage boundaries, stem cells from dental pulp are
also being investigated aiming at cardiac repair [13] and the
regeneration of the central nervous system [14].
Shinya Yamanaka has been recently awarded The Nobel
Prize in Physiology or Medicine 2012 for generating iPSC in
2006 [2]. The recent advances in iPSC technology for dental
applications are in early stages of developments [15–17].
Although iPSC can be generated without using virus, the
protocols are costly and technically challenging. In fact, the
processes to generate iPSC using small molecules, PiggyBac
transposons, minicircle systems or episomal systems are still
under development and optimization and demand high-end
technology. Thus, creating conditions to use iPSC for future
dental applications is far from and the studies published so
far are mostly exploratory [17,18].Stem cells for periodontal and dental pulp tissue
engineering
The routine endodontic treatment stands for the disinfection
and ﬁlling the root canal with synthetic and, most of the
time, inert materials. This procedure frequently removes
additional sound dentin decreasing the fracture resistance
of the remaining structure [12]. Other strategies in Endodon-
tics, such as the use of mineral trioxide aggregate (MTA) or
calcium hydroxide (Ca(OH)2) to induce the formation miner-
alized tissue in incomplete root apices are not clearly pre-
dictable [19].
Stem cells offer a new perspective targeting dental pulp
regeneration and further development of root structure. Both
SHED and DPSC can differentiate into odontoblasts in vivo [10].
DPSCs were capable to regenerate a dental-pulp-like complex
composed of soft-ﬁbrous tissue, mineralized matrix andcs Ref.
enerate a dental pulp-like complex [11,20]
nd dentin regeneration in full length root canals [10,22,23,25,49]
nal both cementum-like mineral and periodontal
luding Sharpey's ﬁbers
[3,32]
differentiate into adipogenic, chrondrogenic and
neages
[5,6,47,53,54]
ogenic and neurogenic differentiation [4,26]
ifferentiate into neural cells and chondrocytes
late immune cells
[55,56]
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structure on the surface of human dentin [11,20,21]. In 2008, a
proof-of-principle work showed that SHED holds the potential
to regenerate the dental pulp. Human tooth slices (1 mm-
thick) were seeded with biodegradable scaffolds with SHED
and transplanted into immunodeﬁcient mice for 28 days. After
this period, the space once occupied by the scaffold was fully
replaced for a dental pulp-like tissue with morphologic char-
acteristics similar to a natural human dental pulp [22]. Later,
using tetracycline staining and confocal microscopy, it was
possible to show that SHED could differentiate into functional
odontoblasts capable of generating tubular dentin [23].
Although these are exciting results, a stem cell-based
approach in regenerative Endodontics needs to fulﬁll the
requirement of regenerating dental pulp in the whole three
dimensional geometry of root canals. Recently, we were able
to proliferate SHED within a full length root canal and to
engineer a dental pulp with soft tissue containing blood
vessels and connective tissue capable of depositing miner-
alized tissue on dentin walls in vivo (Fig. 1) [24,25].
Although SHED and DPSC seem to be the natural candi-
date for functional dental pulp regeneration, SCAP also rises
as an alternative once they have the capacity to undergo
osteo/dentinogenic and neurogenic differentiation and pre-
sent expression pattern of osteo/dentinogenic markers and
growth factor receptors similar to those observed in DPSC [4].
Notably, it was possible to regenerate typical dentine struc-
ture in vivo by seeding human SCAP into a hydroxyapatite/
tricalcium phosphate (HA/TCP) root-shaped constructs [26].
Moreover, this cell type was able to further induce root
formation in cases of apexogenesis in infected immature
tooth with periradicular periodontitis or abscess [27,28].
Other areas that may beneﬁt from the development of
stem cell therapies is Periodontology. Up to date, infection
control allied to either guided bone regeneration or/and
bioabsorbable matrices are the main therapies used to regen-
erate the periodontium tissues and although favorableFig. 1 – Engineering of a dental pulp-like tissue with SHED
seeded in tooth slice and transplanted into the
subcutaneous space of an immunodeﬁcient mouse for 35
days. Further immunohistochemistry analysis for GFP
conﬁrmed that tissue engineered with the root canals is
primarily populated with SHED [25].clinical outcomes have been reported, regenerating the sup-
port tissues remains challenging [29–31].
The level of expression of scleraxis (a transcription factor
highly expressed in mesenchymal progenitors involved in
chondrogenic and/or osteogenic differentiation) by PDLSC
suggests that these cells may exhibit unique properties
compared with other mesenchymal stem cells such as bone
marrow stem cells (BMSC) and DPSC [32]. Transplantation
of PDLSC mixed with ceramic particles into subcutaneous
pockets of mice demonstrated the aptitude of these cells to
form both cementum-like mineral and periodontal ligament
including Sharpey's ﬁbers [3]. One study showed that it was
possible to regenerate the root and periodontal ligament-like
tissue using the co-transplantation of PDLSC with SCAP into
the tooth sockets of miniature pigs. The mineralized root-like
structure formed was encircled with periodontal-like tissue
and was capable of supporting a porcelain crown and restor-
ing normal tooth function [26].
As one could observe, the selection of the cell type to be
used as the impellent power to initiate and propagate the
regeneration is of paramount importance. One example of
this can be illustrated by the attempts of using dental pulp
stem cells for periodontal tissue regeneration. The implanta-
tion of DPSC into periodontal defects resulted in inconsistent
patterns of regeneration reported by different studies. Some
have demonstrated that implantation of DPSC enhanced
regeneration through the generation of well-formed vascu-
larized bone [33,34]. Furthermore, it has been shown that
mixing DPSC and Ca(OH)2 led to more regeneration due to the
increase of the proliferation and mineralization of dental
pulp stem cells [33]. Contrariwise, another study that com-
pared the regenerative potential of PDLSC, periapical follicu-
lar stem cells and DPSC, showed that the latter failed to
increase the extent of regeneration in defects when com-
pared to the control groups that did not receive any stem cells
[35].
Similarly to BMSC, PDLSC were shown to be able to modulate
immune responses and inﬂammatory reactions [36]. Using a
swine model it was possible to reverse periodontitis by trans-
planting allogenic PDLSCs into experimental periodontal bone
defects due to the low immunogenicity and immunosuppressive
function of the stem cells used [37]. This was also true for
humans that have periodontal intra-bony defects regenerated
using autologous periodontal ligament-derived cells, including
PDLSC. These studied inspire that PDLSC transplantation may be
an interesting for the treatment of human periodontitis [38].
Stem cell research does not intend to extinguish safe,
established and reliable treatments (e. g. titanium implants)
but aims for new alternatives that may beneﬁt patients even
more. The tried and tested concept of osseointegration has
certainly been one of the most important advances over the
past 30 years in Dentistry and the multi-million dollar market
of dental implants is inclined to keep increasing. Despite of
the unequivocal qualities (such as affordable cost and design
ﬂexibility), titanium implants has one major drawback: the
lack of periodontal ligament. This can compromise prosthetic
rehabilitations because natural teeth and implant have dif-
ferent mobilities and it is impossible for the patient to
balance the contact and load sensations as the implant is
integrated into bone via an ankylosis type contact and is
S i n g a p o r e D e n t a l J o u r n a l 3 4 ( 2 0 1 3 ) 1 3 – 1 816without proprioceptors [39]. Furthermore, the most relevant
long-term failure mode of dental implants is peri-implantitis
that has an overall frequency of 8% [40]. The development of
new strategies such as the bio-root may provide an alter-
native for titanium implants in cases where the existence of
functional periodontal ligament can beneﬁt the long-term
success of prosthetic rehabilitation [3,26]. However, one of the
major concerns is the costs involved in both development
and implementation of these new approaches. History
has shown that most of the revolutionary technologies
became more affordable with popularization. The price of
one gigabyte, for example, dropped from US$ 200,000 in 1980
to US$ 0,07 in 2013. Hopefully this can be also true for future
tissue engineering approaches under development in
Dentistry.Future challenges for stem cells in Dentistry
Stem cell-based tissue engineering demands the ﬁne orches-
tration of three fundamental elements: scaffold, cells, and
signaling pathway [24].
The scaffold is a temporary structure used to provide a
three-dimensional environment where cells can proliferate,
differentiate and generate the desired tissue [41]. It needs to
allow cell attachment and migration, enable the inﬂux of
oxygen to maintain the cell metabolism and preferably
permit the sustained delivery of growth factors. The scaffold
must present physical properties to support and protect cells
from the environmental mechanical stresses. On the other
hand, the material is expect to degrade once it has served its
purpose of providing a template for regeneration in a rate
compatible with the new tissue formation. Finally, the hand-
ling characteristics need to fulﬁll the clinical situation that
they will be used. For Endodontics, injectable scaffolds are
the logical choice once cells can be spread in the whole space
available disregarding anatomical characteristics such as
saliences, recesses and even curved canals [12,24]. Consider-
ing periodontal regeneration, ﬁber mesh layers or powder
compaction may be preferred to provide a support matrix for
the ingrowth of alveolar bone and periodontium, avoiding
gingival epithelium growth into the defect to be regenerated
[42]. In order to obtain these desired qualities, ﬁne-tuning of
physical characteristics and chemo/mechanical properties of
the scaffolds to be used is critical.
Obtaining and banking stem cells is an expanding busi-
ness. Laboratories worldwide offer the whole package of
collecting and storing dental stem cells for a lower cost as
compared to cord blood stem cells. To maintain cell viability,
collection kits are prepared to keep cells alive and shelter
freshly extracted teeth from temperature changes. Even with
these precautions, the time passed from gathering to arrival
at the processing laboratory must be shorter than 40 h [43].
Although the complete substitution of deciduous to perma-
nent teeth lasts 7 years, providing a good window of oppor-
tunity to obtain SHED, only incisors and canines with at least
one third of root left are known to contain a sufﬁcient
number of stem cells that allow separation and multiplica-
tion [43]. DPSC are obtained from permanent teeth and the
possibilities to gather them are restricted to teeth assigned tobe extracted, such as third molars and pre-molars due to
orthodontics reasons. Conversely, SCAP collected from just
one tooth are capable of providing a large number of stem
cells probably because they have high proliferative potential,
reﬂected in high telomerase activity [44].
Cell signaling is part of a complex system of communica-
tion that rules cell activities and organizes their interactions
[24]. Extracellular signal molecules can act over both short
or long distances and different cell types may have
various reactions to a given extracellular signal molecule.
Even the level of response greatly depends on the concentra-
tion and exposure time of the cell to the stimuli [45].
One example of how complex these interactions can be
illustrated when analyzing the role of bone morphogenetic
proteins (BMP). BMP-2 and -7 were reported to the play a role
in the differentiation of PDLSC and dental follicle stem cells
and in the regeneration of the periodontal attachment appa-
ratus [46,47]. Furthermore, these BMPs are strongly involved
in the odontoblastic differentiation processes [48,49].
Both BMP-2 and 7 are known to present inductive effects in
reparative dentinogenesis [50,51] however it has been shown
that SHED responded potently to BMP-2 and more modestly
to BMP-7 while undergoing through odontoblastic differentia-
tion. Furthermore, using neutralizing antibodies for BMP's,
it was possible to show that BMP-2 signaling and not BMP-7
was actually required for odontoblastic differentiation [49]. By
observing the different effects of only two members of the
BMP family used for distinct purposes, it is possible to visu-
alize that many interactions among the plethora of naturally
occurring molecules in different stages of cell differentiation
make the signalling system extremely complex to be fully
simulated in the laboratory.Conclusion
The development of stem cells technologies and biomaterials
can change the archetype where lost or damaged tissues will
not be treated using only materials tolerated by the body but
congregating biomaterials and biological principles to deliver
to the body its original construction. However, stem cell-
based therapies are still far from leaving laboratory benches
for the chairside [52]. Identifying speciﬁc growth factors and
their mechanisms in the natural processes will deﬁnitely
help improve our understanding of molecular triggering and
regulating processes among stem cells, scaffold, bioactive
molecules and host tissues is necessary to achieve proper
tissue regeneration. The investments in basic research and
education, allied to the rise of commercial services to isolate
and to provide stem cells and development of new materials
to support their growth and differentiation shed a light in the
promise for using stem cells as a clinical practice in the
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